Intensive Cholesterol-Lowering Within 24 Hours of PCI Perioperative Period

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 2442 participants.

Also called NCT07290699

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 2,442 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07290699
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07290699. Randomized; no masking; primary purpose treatment. Start 2026-01-01 (anticipated); primary completion 2027-08-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Intensive Cholesterol-Lowering Within 24 Hours of PCI Perioperative Period
Acronym
INCLINE-AMI
Condition
STEMI - ST Elevation Myocardial Infarction
Condition
NSTEMI - Non-ST Segment Elevation Myocardial Infarction (MI)
Intervention (Drug)
Recaticimab
Lead sponsor
Second Affiliated Hospital of Nanchang University (class: other)
Collaborator
First Affiliated Hospital of Gannan Medical University (class: other)
Collaborator
Jiujiang No.1 People's Hospital (class: other)
Collaborator
First People's Hospital of FuZhou (class: other)
Collaborator
Yueyang Central Hospital (class: other)
Collaborator
The First People's Hospital of Changde City (class: other)
Collaborator
ZhuZhou Central Hospital (class: other)
Collaborator
Xiangtan Central Hospital (class: other)
Collaborator
Loudi Central Hospital (class: other)

Record details

Record id
cardio:ct-nct07290699
Content hash
4eee6846084ce496b13f0612b7bc5923f31d9b201cd55afa7e9ff0b43fd3f6d5